| A Study of Evacetrapib in Healthy Female Participants (NCT01746732) | Eli Lilly and Company | 2012-12-01 |
| Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot (NCT01731067) | Jules Desmeules | 2012-11-01 |
| CYP2B6 Polymorphisms in Methadone Disposition (NCT01648283) | Washington University School of Medicine | 2012-11-01 |
| Brain Imaging Study of F17464 (NCT01689038) | Pierre Fabre Medicament | 2012-11-01 |
| A Comparison of the Bioavailability of OZ439 When Delivered Directly to the Small Intestine, or Via the Oral Route (NCT01732588) | Medicines for Malaria Venture | 2012-11-01 |
| First in Human Study of an Anti-Toll-like Receptor 4 (TLR4) Monoclonal Antibody (NI-0101) in Adult Healthy Volunteers (NCT01808469) | Light Chain Bioscience - Novimmune SA | 2012-11-01 |
| Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet (NCT05436769) | University of Karachi | 2012-10-23 |
| Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males (NCT01725009) | UCB Japan Co. Ltd. | 2012-10-01 |
| Evaluation Of The Potential Effect That The Administration Of Food Or Antacid Medication May Have In The Oral Absorption Of Dacomitinib (PF-00299804) (NCT01702506) | Pfizer | 2012-10-01 |
| A Open-label, Three-period, Partial-replicate Design Study to Evaluate the Inter- and Intrasubject Variability of the Avatrombopag To-be-marketed Formulation Administered as Single Doses of 40 mg to Healthy Subjects Receiving a Low-fat Meal (NCT01759394) | Eisai Inc. | 2012-10-01 |
| A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male Subjects (NCT02088918) | IlDong Pharmaceutical Co Ltd | 2012-10-01 |
| Polymorphism of the IgH Locus Regulatory Region as a Prognostic Factor During Immune Pathologies. (NCT01715623) | University Hospital, Limoges | 2012-10-01 |
| Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786) (NCT01720576) | Regeneron Pharmaceuticals | 2012-10-01 |
| In Vivo Inhibition Profile of CYP2C9 by Pineapple Juice (NCT01649492) | Universitaire Ziekenhuizen KU Leuven | 2012-09-01 |
| A Study to Investigate the Safety and Tolerability of a New Inhaled Formulation of RV568 in Healthy Volunteers (NCT01661244) | Respivert Ltd | 2012-09-01 |
| The Effects of GLA (5 mcg) on Human Volunteers (NCT01864876) | Access to Advanced Health Institute (AAHI) | 2012-09-01 |
| A Study to Investigate the Drug-Drug Interactions of Brivaracetam and Ethanol in Healthy Male Subjects (NCT01710670) | UCB Pharma SA | 2012-09-01 |
| Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX® (NCT03796351) | Medy-Tox | 2012-09-01 |
| Sunlight Exposure and Vitamin D Status of Children of South Asian Ethnicity Living in the UK (NCT01623414) | University of Manchester | 2012-09-01 |
| A Bioequivalence Study Comparing A Fixed Dose Combination Formulation, Rin 150 And Individual Reference Drugs In Healthy Volunteers (NCT02014272) | Pfizer | 2012-09-01 |
| Multiple-Dose Study of Effect of Bardoxolone Methyl on QT/QTC Interval Volunteers (NCT01689116) | Biogen | 2012-08-31 |
| Drug Interaction Study of Multiple Doses of Isavuconazole and Single Dose of Atorvastatin (NCT01635946) | Astellas Pharma Global Development, Inc. | 2012-08-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects (NCT01702649) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-08-01 |
| A Study of Dulaglutide in Chinese Participants (NCT01667900) | Eli Lilly and Company | 2012-08-01 |
| Finasteride, Dutasteride and Insulin Action (NCT01923090) | University of Birmingham | 2012-08-01 |
| ANX-042 Healthy Volunteer Dose Escalation Study (NCT01638104) | Mayo Clinic | 2012-08-01 |
| A Study to Assess the Safety and Pharmacokinetics of Isavuconazole in Healthy Chinese Volunteers (NCT01555918) | Astellas Pharma Inc | 2012-08-01 |
| Bioequivalence of Orfadin Suspension Compared to Orfadin Capsules, and the Effect of Food on the Bioavailability of the Suspension (NCT01682538) | Swedish Orphan Biovitrum | 2012-08-01 |
| Ultrasound Comparison of the Surface of the Subclavian and the Axillary Vein Versus the Surface of the Subclavian Vein (NCT01647815) | Centre Hospitalier Universitaire de Nīmes | 2012-08-01 |
| A Study of LY3015014 in Healthy Participants With High Cholesterol (NCT01671085) | Eli Lilly and Company | 2012-08-01 |
| GLASSIA Infusion Rate Study (NCT01651351) | Baxalta now part of Shire | 2012-07-31 |
| A Study of LY3006072 in Healthy Participants (NCT01640249) | Eli Lilly and Company | 2012-07-24 |
| Bisphenol A Controlled Exposure Study (NCT01573429) | National Institute of Environmental Health Sciences (NIEHS) | 2012-07-18 |
| A Randomized, Open Label Study to Compare the Current Phase II and Planned Phase III Capsule Formulation of AZD6244 (NCT01635023) | AstraZeneca | 2012-07-01 |
| Study in Healthy Volunteers to Establish the Bioequivalence of Two Different Manufacturers. (NCT01632449) | Biogen | 2012-07-01 |
| A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib (NCT01645085) | AstraZeneca | 2012-07-01 |
| A Study of LY2963016 in Healthy Participants (NCT01634165) | Eli Lilly and Company | 2012-07-01 |
| A Study of LY2605541 Versus Insulin Glargine on Blood Sugar (NCT01654380) | Eli Lilly and Company | 2012-07-01 |
| A Study to Assess Safety, Tolerability and Pharmacokinetics of Ceftaroline in Healthy Subjects (NCT01612507) | Pfizer | 2012-07-01 |
| A Study of Prasugrel in Healthy Participants (NCT01648790) | Eli Lilly and Company | 2012-07-01 |
| An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers (NCT01598363) | Biogen | 2012-06-30 |
| A Study Evaluating the Effect of a Single-dose Oral Administration of Nemonoxacin Capsule on QTc Intervals and Heart Rhythms of Healthy Subjects and the Influence of Food Intake on QTc Intervals and Pharmacokinetic Characteristics (NCT03362853) | TaiGen Biotechnology Co., Ltd. | 2012-06-25 |
| Drug-drug Interaction Study Between Lopinavir/Ritonavir and Isavuconazole (NCT01660477) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| Study in Healthy Volunteers of the Bioavailability of Dexpramipexole Tablets and Food Effects (NCT01607034) | Knopp Biosciences | 2012-06-01 |
| Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects (NCT01657825) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| A Study of LY3015014 in Otherwise Healthy Participants With High Low-density Lipoprotein (LDL) Cholesterol (NCT01618916) | Eli Lilly and Company | 2012-06-01 |
| A Single Dose Study of LY3023703 in Healthy Participants (NCT01632579) | Eli Lilly and Company | 2012-06-01 |
| Phase 1 Safety Study of Single and Multi-Dose Topically Applied OLT1177 Gel in Healthy Subjects (NCT01636141) | Olatec Therapeutics, Inc. | 2012-06-01 |
| Reliability of Measuring Conditioned Pain Modulation With the Nociceptive Withdrawal Reflex (NCT01636440) | Insel Gruppe AG, University Hospital Bern | 2012-06-01 |
| Study of the Pharmacokinetics of Isavuconazole in Healthy Non-Elderly and Elderly Male and Female Subjects (NCT01657890) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| A Phase I Study to Compare 3 Different Strengths of an Extended Release Formulation of ASP015K to an Immediate Release Formulation of ASP015K (NCT01686217) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| A Multiple-dose Study of LY3031207 in Healthy Participants (NCT01632566) | Eli Lilly and Company | 2012-06-01 |
| Drug Interaction Study of Multiple Doses of Isavuconazole and a Single Dose of Bupropion (NCT01635972) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| Screening for Frailty at Home (NCT02852200) | CHU de Reims | 2012-06-01 |
| Cortical Excitability Using Transcranial Magnetic Stimulation and Neuronavigation Device (NCT02596789) | University Hospital, Grenoble | 2012-06-01 |
| Anesthetic Effect Duration Assessment (NCT01545765) | Galderma R&D | 2012-05-01 |
| A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401 (NCT01627002) | ProtAffin Biotechnologie AG | 2012-05-01 |
| Evaluation of Salt Sensitivity in Young Adults (NCT02588352) | NYU Langone Health | 2012-05-01 |
| Influence of Gravity on Dexterity, Hand-eye Coordination and Perception of Orientation and Distances (NCT02563249) | University Hospital, Caen | 2012-05-01 |
| Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study (NCT01597310) | Knopp Biosciences | 2012-05-01 |
| Biomarker Identification in Orthopaedic & Oral Maxillofacial Surgery Subjects to Identify Risks of Bisphosphonate Use (NCT01875458) | University of Pennsylvania | 2012-04-13 |
| MOTIONPODTM Validation in Free-living Conditio (NCT03235583) | Hospices Civils de Lyon | 2012-04-02 |
| Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers (NCT01383096) | Medicines for Malaria Venture | 2012-04-01 |
| A Study of LY3016859 in Healthy Volunteers (NCT01545583) | Eli Lilly and Company | 2012-04-01 |
| Drug Interaction Study of Isavuconazole and Oral Contraceptive Containing Ethinyl Estradiol and Norethindrone (NCT01597986) | Astellas Pharma Global Development, Inc. | 2012-04-01 |
| A Study of LY2979165 and LY2140023 in Healthy Volunteers (NCT01524237) | Eli Lilly and Company | 2012-04-01 |
| Effects of Levocetirizine and Hydroxyzine on Cognitive and Psychomotor Functioning During Simulated Diving (NCT01496911) | Utrecht Institute for Pharmaceutical Sciences | 2012-04-01 |
| Drug Interaction Study of Isavuconazole and Methadone (NCT01582425) | Astellas Pharma Global Development, Inc. | 2012-04-01 |
| A Study of LY2140023 in Healthy Males and Females (NCT01591330) | Denovo Biopharma LLC | 2012-04-01 |
| Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib (NCT01544140) | Sanofi | 2012-04-01 |
| Effects of S. Boulardii and Amoxicillin/Clavulanate on Gut Microbiota (NCT01473368) | Beth Israel Deaconess Medical Center | 2012-04-01 |
| Evaluation of 3D Selection Tasks in Parabolic Flight Conditions: Pointing Task in Augmented Reality User Interfaces (NCT02563236) | University Hospital, Caen | 2012-03-01 |
| Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects (NCT01565018) | UCB Pharma | 2012-03-01 |
| Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines (NCT01461447) | Muhimbili University of Health and Allied Sciences | 2012-03-01 |
| Intravenous/Subcutaneous FIH Study of REGN1154 in Healthy Volunteers (NCT01540539) | Regeneron Pharmaceuticals | 2012-03-01 |
| Study of the Effect of Repeat Doses of Isavuconazole on Cardiac Repolarization (NCT01565720) | Astellas Pharma Global Development, Inc. | 2012-03-01 |
| A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435. (NCT01571570) | Janssen R&D Ireland | 2012-03-01 |
| Study on the Effects of DA-9701 on Gastrointestinal Motility on Healthy Adult Volunteers (NCT01669772) | Myung-gui Choi | 2012-03-01 |
| Safety Evaluation of Bowel Cleansing Regimen for PillCam® COLON 2 Capsule Endoscopy (NCT01575093) | Medtronic - MITG | 2012-03-01 |
| Drug Interaction Study of Isavuconazole and Digoxin (NCT01582412) | Astellas Pharma Global Development, Inc. | 2012-03-01 |
| Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With Vandetanib (NCT01561781) | Sanofi | 2012-03-01 |
| Study of the Effect of Renal Impairment on the Pharmacokinetics of Isavuconazole. (NCT01555866) | Astellas Pharma Global Development, Inc. | 2012-03-01 |
| Weight Management Interactions in a Virtual Clinical Environment (NCT01443910) | National Human Genome Research Institute (NHGRI) | 2012-02-29 |
| TRACERx Renal CAPTURE Sub-study (NCT03226886) | Royal Marsden NHS Foundation Trust | 2012-02-05 |
| Serotonergic System and Violent Video Games (NCT01644071) | RWTH Aachen University | 2012-02-01 |
| A Study of LY2484595 on the Electrical Activity of the Heart (NCT01537887) | Eli Lilly and Company | 2012-02-01 |
| Effects of Xylooligosarcharide on Composition of the Human Colonic Microflora (NCT01861964) | University of California, Los Angeles | 2012-02-01 |
| Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240 (NCT01582399) | Astellas Pharma Global Development, Inc. | 2012-02-01 |
| Assessment of Blood Glucose Changes in Healthy Volunteers After BMS-754807 Alone or BMS-754807 With Metformin (NCT01525823) | Bristol-Myers Squibb | 2012-02-01 |
| Study in Healthy Volunteers to Investigate the Effects of Ketoconazole on the Pharmacokinetics of NKTR-118 (NCT01520896) | AstraZeneca | 2012-02-01 |
| A Study of LY2886721 in Healthy Participants (NCT01534273) | Eli Lilly and Company | 2012-02-01 |
| Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine (NCT01540500) | Vanda Pharmaceuticals | 2012-02-01 |
| A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants (NCT01515358) | Eli Lilly and Company | 2012-02-01 |
| A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge (NCT01539473) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-02-01 |
| EXPAREL Dose-Response for Single-Injection Femoral Nerve Blocks (NCT01349140) | University of California, San Diego | 2012-02-01 |
| A Study of LY3025876 in Healthy Volunteers (NCT01528124) | Eli Lilly and Company | 2012-02-01 |
| The Role of Endocannabinoids in Insulin Production and Action (NCT01517100) | National Institute on Aging (NIA) | 2012-01-05 |
| A Study to Assess the Safety and Tolerability of Single Ascending Doses of REGN1033(SAR391786) (NCT01507402) | Regeneron Pharmaceuticals | 2012-01-01 |
| Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia (NCT01513200) | Stealth BioTherapeutics Inc. | 2012-01-01 |
| A Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Subjects With IgE >= 30 IU/mL (NCT01544348) | MedImmune LLC | 2012-01-01 |